Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - TOTAL CURRENT ASSETS
Total Current Assets KYMR - Kymera Therapeutics, Inc.
405 M
LAST VALUE
-15.50%
2 YEAR CAGR
57.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR